US Patent Issued to DANA-FARBER CANCER INSTITUTE on July 14 for "HCK as a therapeutic target in MYD88 mutated diseases" (American, Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,842, issued on July 14, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston).

"HCK as a therapeutic target in MYD88 mutated diseases" was invented by Steven P. Treon (Jamaica Plain, Mass.), Nathanael S. Gray (Stanford, Calif.), Sara Jean Buhrlage (Somerville, Mass.), Guang Yang (Natick, Mass.), Jinhua Wang (Winchester, Mass.) and Li Tan (Pudong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof. The provided compounds may...